A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study. - Eriksen, Martina; Pfeiffer, Per; Rohrberg, Kristoffer Staal; Yde, Christina Westmose; Petersen, Lone Nørgård; Poulsen, Laurids Østergaard; Qvortrup, Camilla (BMC Cancer, 2022)